Ocular Therapeutix Stock Price (NASDAQ:OCUL)

Add to My Stocks
$6.14 $0.06 (0.97%) OCUL stock closing price Sep 17, 2018 (Closing)
Prev Close* : $6.2
Market Cap:
$239.27M
Day Low: $6.13
52 Week Low: $3.30
Open: $6.19
Volume: -
Day High: $6.33
52 Week High: $8.28
Dividend:
0.00

Latest Stock Market News

Latest Articles

Ocular Therapeutix News - From Partners

OCUL Stockcharts

View OCUL PE ratio, PS ratio stocks charts and compare with peers.
OCUL Chart
Note: Compare Ocular Therapeutix stock price history with the index and industry peers.

Ocular Therapeutix Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
115.22
PB ratio (
price to book ratio
)
5.62

Ocular Therapeutix Returns

ROE
(return on equity)
-137%

Ocular Therapeutix Financial Ratios

Asset Turnover
0.04
Receivables Turnover
8.62
Debt to Equity
0.34
Dividend Yield
0%

OCUL Industry Peers

Company Price Change (%)
Foamix (FOMX)5.740.44 (7.12%)
Aratana Therapeutics (PETX)5.340 (0%)
Novartis (NVS)85.130.09 (0.11%)
Melinta Therapt (MLNT)4.10.15 (3.53%)
Regeneron Pharma (REGN)386.495.68 (1.45%)
Adverum (ADVM)5.90.25 (4.07%)
Ophthotech (OPHT)2.350.04 (1.67%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Neptune Tech. & Bio. (NEPT)4.210.39 (10.21%)
Rigel Pharma (RIGL)3.410.2 (6.23%)
Galectin Therapeutics (GALT)5.740.32 (5.9%)
Ionis Pharma (IONS)48.192.19 (4.76%)
Spectrum Pharma (SPPI)20.130.55 (2.81%)
Corcept Therapeutics (CORT)14.740.35 (2.43%)
Grifols (GRFS)20.420.35 (1.74%)
Top gainers from Medical-Drugs industry
* As of Sep 18, 2018
CompanyPriceChange (%)
Recro Pharma (REPH)7.70.86 (10.05%)
CASI Pharma (CASI)5.630.59 (9.49%)
Achaogen (AKAO)4.110.36 (8.05%)
ArQule (ARQL)5.040.43 (7.86%)
CORREVIO PHARMA (CORV)4.30.33 (7.13%)
Ironwood Pharma (IRWD)17.091.18 (6.46%)
Aerie Pharma (AERI)56.153 (5.07%)
Top losers from Medical-Drugs industry
* As of Sep 18, 2018

Ocular Therapeutix Inc Stock News - Partner Headlines

Ocular Therapeutix Financial Statements

income statement20172016201520142013
Net Sales or Revenues1.92M1.88M1.75M--
Net Income-63.38M-44.7M-39.74M-28.64M-13.31M
Total Operating Expense63.38M44.76M39.62M27.77M12.89M
View Ocular Therapeutix income statement
balance sheet20172016201520142013
Total Assets55.43M74.93M110.3M78.19M19.14M
Total Liabilities29.28M22.93M20.71M19.49M78.61M
Shareholders Equity26.14M52M89.58M58.69M-59.47M
View Ocular Therapeutix balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities3.55M2.07M-2.16M-0.24M
Net Cash from (used by) Operating Activities-50.47M-34M-33.74M-20.49M-12.64M
Increase (Decrease) in Prop Plant And Equipment-8.24M-1.91M-1.77M-1.26M-0.38M
View Ocular Therapeutix cash flow statement

Ocular Therapeutix Stock Message Board

An investor needs to spend $6.14 to buy OCUL stock, as the closing Ocular Therapeutix stock price is $6.14. Ocular Therapeutix market capitalization is $239.27M and it represents the total market value of OCUL stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Ocular Therapeutix stock analysis.

The terms stocks and shares mean the same thing. For Ex: Ocular Therapeutix stock price and Ocular Therapeutix share price mean the same thing. 237,775 shares were traded with a closing stock price of $6.14 as of Sep 17, 2018, as can be seen from Ocular Therapeutix stock quote. One can view Ocular Therapeutix stock chart to follow the stock price trend. Ocular Therapeutix paid 0.00 stock dividends to its shareholders during last quarter. Ocular Therapeutix stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.